Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2020 09:10 ET | Source: Vaxil Bio Ltd.

VAXIL CHANGES WEBSITE DOMAIN NAME, PROVIDES UPDATE ON THE EXERCISE OF WARRANTS AND RECEIVES FINAL TSXV EXCHANGE APPROVAL ON THE DEBENTURE FINANCINGS

Not for distribution by US newswire or in United States NESS-ZIONA, ISRAEL, March 18, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
March 16, 2020 09:10 ET | Source: Vaxil Bio Ltd.

Vaxil Provides Update Website, Lab Work and the Exercise of Warrants

NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, March 16, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
March 10, 2020 09:10 ET | Source: Vaxil Bio Ltd.

VAXIL APPLIES FOR CORONAVIRUS VACCINE PATENT UNDER ITS ANTI-INFECTIVE VACCINES PLATFORM AND PROVIDES UPDATE ON THE EXERCISE OF WARRANTS

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 10, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
March 04, 2020 09:20 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Closing of Bridge Financing and Provides Update on Corona Virus Vaccine Work

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 04, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
February 21, 2020 09:20 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Financing Update

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 21, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
February 18, 2020 12:28 ET | Source: Vaxil Bio Ltd.

Vaxil Provides Clarification and Further Information on the Possible Identification of a Corona Virus Vaccine

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
February 13, 2020 16:05 ET | Source: Vaxil Bio Ltd.

Vaxil Announces the Identification of a Potential Corona Virus Vaccine and Provides an Update in the Previously Announced Debt Financing

NESS-ZIONA, Israel, Feb. 13, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
January 28, 2020 10:14 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Financing Update

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
November 26, 2019 16:02 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Private Placement Extension

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 26, 2019 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
November 04, 2019 16:05 ET | Source: Vaxil Bio Ltd.

Vaxil’s Annual and Special General Meeting

Not for distribution by US newswire or in United States TORONTO, Nov. 04, 2019 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), announces that at the Company's...